Molecular detection of GNNK- and GNNK+ c-kit isoforms: A new tool for risk stratification in adult acute myeloid leukaemia [10]

Leukemia

Volumn 21, Issue 9, 2007, Pages 2056-2058

  Guerrini, F ^a   Galimberti, S ^a   Ciabatti, E ^a   Brizzi, S ^a   Testi, R ^a   Pollastrini, A ^a   Falini, B ^b   Petrini, M ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; CD14 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; DAUNORUBICIN; ETOPOSIDE; HLA DR ANTIGEN; IDARUBICIN; IMATINIB; ISOPROTEIN; MICROSOMAL AMINOPEPTIDASE; MITOXANTRONE; NUCLEOPHOSMIN; PROTEIN GNNK; SORAFENIB; STEM CELL FACTOR; STEM CELL FACTOR A; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GENE AMPLIFICATION; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; KARYOTYPE; LETTER; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME;

EID: 34548192289     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404726     Document Type: Letter

References (8)

1. Cairoli R, Beghini A, Grillo G, Nadali G, Elice F, Ripamonti CB et al. Prognostic impact of c-KIT mutations in core binding factor leukaemias: An Italian retrospective study. Blood 2006; 107: 3463-3468.
2. Caruana G, Cambareri AC, Ashman LK. Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblasts. Oncogene 1999; 18: 5573-5581.
3. Galimberti S, Rossi A, Palumbo GA, Morabito F, Guerrini F, Vincelli I et al. FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia. Anticancer Res 2003; 23: 3419-3426.
4. Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med 2005; 352: 254-266. Erratum in: N Engl J Med 2005; 352: 740.
5. Theou N, Tabone S, Saffroy R, Le Cesne A, Julie C, Cortez A et al. High expression of both mutant and wild-type alleles of c-kit in gastrointestinal stromal tumors. Biochim Biophys Acta 2004; 1688: 250-256.
6. Voytyuk O, Lennartsson J, Mogi A, Caruana G, Courtneidge S, Ashman LK et al. Src family kinases are involved in the differential signaling from two splice forms of c-Kit. J Biol Chem 2003; 278: 9159-9166.
7. Heidel F, Cortes J, Rucker FG, Aulitzky W, Letvak L, Kindler T et al. Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib. Cancer 2007; 109: 907-914.
8. Rahmani M, Davis EM, Bauer C, Dent P, Grant S. Apoptosis induced by the kinase inhibitor BAY 43-9006 in human leukemia cells involves downregulation of Mcl-1 through inhibition of translation. J Biol Chem 2005; 280: 35217-35227.